Sentinel Trust’s Allergan plc AGN Stock Holding History

Sentinel Trust’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-7,270	Closed	-$1.22M	–	123
2018 Q1	$1.22M	Sell	7,270 -2,540	-26%	-$426K	0.26%	79
2017 Q4	$1.6M	Buy	+9,810	New	+$1.76M	0.33%	77

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Sentinel Trust's AGN Position: Q2 2018 in Review

Sentinel Trust sold out of Allergan plc (AGN) in Q2 2018, closing a stake of 7,270 shares — an estimated $1.22M sold.

Sentinel Trust first reported a position in AGN in Q4 2017 and held it in 2 quarters. The position peaked at $1.6M in Q4 2017. 1,044 funds tracked by Wall St. Rank hold AGN as of Q2 2018.

Sentinel Trust reported no remaining Allergan plc position as of Q2 2018 after selling out during the quarter.
Sentinel Trust sold 7,270 Allergan plc shares in Q2 2018, an estimated $1.22M.
Sentinel Trust first reported a position in Allergan plc in Q4 2017 and held it in 2 quarters.
Sentinel Trust's Allergan plc position peaked at $1.6M in Q4 2017.
1,044 funds tracked by Wall St. Rank held Allergan plc as of Q2 2018.

Based on Sentinel Trust's 13F filing for Q2 2018, filed 15 Aug 2018.